Diagnosis and management of neuropsychiatric SLE
Top Cited Papers
- 11 February 2014
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Rheumatology
- Vol. 10 (6), 338-347
- https://doi.org/10.1038/nrrheum.2014.15
Abstract
Nervous system involvement in systemic lupus erythematosus (SLE) can manifest as a range of neurological and psychiatric features, which are classified using the ACR case definitions for 19 neuropsychiatric syndromes. Approximately one-third of all neuropsychiatric syndromes in patients with SLE are primary manifestations of SLE-related autoimmunity, with seizure disorders, cerebrovascular disease, acute confusional state and neuropathy being the most common. Such primary neuropsychiatric SLE (NPSLE) events are a consequence either of microvasculopathy and thrombosis, or of autoantibodies and inflammatory mediators. Diagnosis of NPSLE requires the exclusion of other causes, and clinical assessment directs the selection of appropriate investigations. These investigations include measurement of autoantibodies, analysis of cerebrospinal fluid, electrophysiological studies, neuropsychological assessment and neuroimaging to evaluate brain structure and function. Treatment involves the management of comorbidities contributing to the neuropsychiatric event, use of symptomatic therapies, and more specific interventions with either anticoagulation or immunosuppressive agents, depending upon the primary immunopathogenetic mechanism. Although the prognosis is variable, studies suggest a more favourable outcome for primary NPSLE manifestations compared with neuropsychiatric events attributable to non-SLE causes.Keywords
This publication has 118 references indexed in Scilit:
- Memantine in Systemic Lupus Erythematosus: A Randomized, Double-Blind Placebo-Controlled TrialSeminars in Arthritis and Rheumatism, 2011
- Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosusAnnals Of The Rheumatic Diseases, 2011
- Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosusArthritis Care & Research, 2010
- Assessment of cognitive function in systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis by computerized neuropsychological testsArthritis & Rheumatism, 2010
- Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosusAnnals Of The Rheumatic Diseases, 2009
- Association of cerebrospinal fluid anti-ribosomal P protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosusArthritis Research & Therapy, 2007
- Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous systemAnnals Of The Rheumatic Diseases, 2006
- Relationship between clinical factors and neuropsychiatric manifestations in systemic lupus erythematosusClinical Rheumatology, 2005
- Clinical and Immunologic Effects of Monthly Administration of Intravenous Cyclophosphamide in Severe Systemic Lupus ErythematosusThe New England Journal of Medicine, 1988
- Association between Lupus Psychosis and Antiribosomal P Protein AntibodiesThe New England Journal of Medicine, 1987